Business Standard

Cough syrup deaths: Centre, UP team inspect pharma firm's Noida unit

Cough syrup maker linked to Uzbekistan deaths halts production; samples of Dok-1 Max sent for analysis

cough syrup, medicine, cold
Premium

According to news agency ANI, Marion Biotech has halted the production of Dok-1 Max. | Representative/ File Image

Sohini Das Mumbai
A team of drug inspectors from the Centre and the Food Safety and Drug Administration (FSDA) of Uttar Pradesh (UP) visited the Noida facility of Marion Biotech and sent samples for testing. This comes in the aftermath of drug exports from India coming under fire again, with Uzbekistan reporting deaths of 18 children allegedly linked to syrup and tablet consumption of Marion Biotech’s cold medication. Uzbekistan has initiated legal action against the company.

Union Health Minister Mansukh Mandaviya said in a series of tweets that the Central Drugs Standard Control Organisation (CDSCO) has been in regular contact with the national drug

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 29 2022 | 2:47 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com